Covid-19 l ‘Not right to compare hydroxychloroquine & remdesivir’: DG CSIR
Published on May 05, 2020 02:16 pm IST
As drug trials continue to combat Covid-19, DG of Council of Science and Industrial research has said that it is unfair to compare hydroxychloroquine & remdesivir. Dr. Shekar C Mande said that even US has approved remdesivir only for critically ill patients and added that it's difficult to make a conclusion till the trial of the drugs is not complete. Watch the video for all the details.
RELATED VIDEOS
India Silently Rushes Warships Near Houthi Territory After U.S. Forms Red Sea Force | Watch
Published on Dec 19, 2023 08:38 pm IST
India calls-out W.H.O Covid death data at Geneva; conveys ‘disappointment’
Published on May 24, 2022 07:41 am IST
Paid Covid booster doses for Indian adults: Prices, Availability | Key details
Published on Jul 25, 2023 03:21 pm IST
How Shanghai is grappling with biggest-ever Covid outbreak
Published on Apr 06, 2022 11:08 pm IST
XE a ‘recombinant’: What we know of the new Covid variant reported from Mumbai
Published on Apr 06, 2022 09:56 pm IST
PM Modi clarifies on migrant crisis; says, ‘States imposed lockdown first’
Published on Feb 10, 2022 09:08 am IST
Hi, {{name}}
Sign out
{{planName}}
{{^userSubscribed}}
{{/userSubscribed}}